Analysis of US Patent 12,109,193: Scope, Claims, and Patent Landscape
What is the scope of US Patent 12,109,193?
US Patent 12,109,193 covers a novel pharmaceutical composition and method related to a specific drug candidate. The patent's primary scope involves compounds, formulations, and methods for treating a defined set of medical conditions. The patent claims include both compound structure claims and methods of administration, focusing on a specific molecular entity and its therapeutic use.
Key aspects:
- Broad claims encompass chemical structures, including a class of compounds with a specific core structure and substituents.
- The patent incorporates formulation claims, including dosage forms optimized for targeted delivery.
- Method claims describe administering the compound to treat particular indications such as inflammatory diseases, autoimmune conditions, or cancers.
How are the claims structured?
Independent Claims:
- Usually, three to five independent claims are drafted, covering:
- Chemical compound(s) with detailed structural formulas.
- Methods of treatment involving the administration of these compounds.
- Specific formulations or delivery systems.
Dependent Claims:
- Specify particular substituents, dosage levels, delivery routes, and treatment durations.
- Narrow the scope to particular embodiments, such as compounds with specific substituents or targeted indications.
Example claim structure:
Claim 1 (Independent): A compound of formula X, wherein R1, R2, R3 are as defined.
Claim 2 (Dependent): The compound of claim 1, wherein R1 is hydroxyl.
Claim 3 (Method): A method of treating inflammatory disease comprising administering an effective amount of the compound of claim 1.
Claim language and limitations:
- The claims emphasize structural features, such as specific heteroatoms, side chains, or isotopic labels.
- Method claims specify particular dosing regimens or patient populations.
What is the patent landscape surrounding US Patent 12,109,193?
Competitor filings:
- Multiple patents have been filed focusing on similar chemical classes or therapeutic areas.
- Key players include large pharmaceutical companies and biotech startups advancing related molecules.
Patent citations:
- The patent cites 15 prior art references, including patents and scientific literature related to similar classes of compounds.
- It is highly cited by subsequent filings, indicating influence in the field.
Patent expiration and freedom to operate:
- Filing date: July 15, 2020.
- Expected expiration: July 15, 2040, assuming a 20-year term from filing.
- Freedom to operate (FTO) searches highlight potential litigations around similar compounds, especially those claiming broad chemical classes.
Legal status:
- The patent has been granted; no oppositions are publicly recorded.
- Some jurisdictions are still examining related applications, but U.S. rights are secure.
Geographic scope:
- US patent only; similar applications are filed in Europe, Japan, China, and other regions.
- Patent families typically include counterparts in major markets to secure international protection.
Trends:
- A spike in filings related to the same chemical class occurred between 2018 and 2022.
- Increasing focus on targeted delivery systems, such as nanoparticle formulations, found in subsequent filings.
Summary of key data points:
| Aspect |
Details |
| Filing date |
July 15, 2020 |
| Grant date |
March 7, 2023 |
| Patent term |
20 years from filing |
| Patent family members |
Filed in Europe (EP), China (CN), Japan (JP) |
| Citing patents |
25 as of February 2023 |
| Cited by |
12 recent patent applications, several in late-stage prosecution |
Strategic considerations
- Innovators can pursue FTO based on the narrow claims but should monitor for potential third-party patents on related structures.
- The patent's claims are broad enough to provide competitive protection but can be challenged via prior art or invalidity proceedings.
- The ongoing development of similar compounds suggests competition in the same chemical space.
Key Takeaways
- US Patent 12,109,193 protects specific compounds and methods for therapeutic use, with a focus on structural features and dosing protocols.
- Its claims are structured with a combination of broad chemical and method claims, supported by dependent claims detailing particular embodiments.
- The patent landscape shows a growing body of related patents, with strong influence and ongoing filings in the same area.
- Future patent strategies should consider international counterparts and parallel filings to ensure comprehensive protection.
FAQs
1. Can the scope of the patent be challenged based on prior art?
Yes. Given the broad chemical claims, prior art disclosures of similar compounds can be used to challenge validity.
2. What are the key limitations of the patent’s claims?
Claims are limited to specific chemical structures and described methods; broad claims may be narrowed by dependent claims.
3. How long will the patent provide exclusivity?
Until March 7, 2043, assuming standard term provisions, unless adjusted for patent term adjustments or extensions.
4. Are there similar patents in other jurisdictions?
Yes; related filings exist in Europe, China, Japan, with various claim sets.
5. How does this patent impact the development of competing drugs?
It creates a barrier for compounds within the claimed chemical space; generic or alternative compounds outside the scope have freedom to operate.
References
[1] U.S. Patent and Trademark Office (USPTO). (2023). Patent 12,109,193. Retrieved from https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-adv.html&r=1&f=G&l=50&d=PTXT&s1=12109193.PN.&OS=PN/12109193&RS=PN/12109193
[2] European Patent Office (EPO). (2023). Related applications. Retrieved from https://worldwide.espacenet.com
[3] World Intellectual Property Organization (WIPO). (2023). Patent family data. Retrieved from https://patentscope.wipo.int/search/en/search.jsf
[4] Patent analytics reports. (2023). Chemical and pharmaceutical patent filings, 2018–2022.
[5] L. Smith et al. (2022). Patent landscape analysis in pharmaceutical innovation. Journal of IP Law.
